Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Assays and screens; drug platforms

TECHNOLOGY: Cellular assays; cell therapies

A sequencing-based method of identifying neoantigen-specific TCRs could be used to develop personalized T cell therapies for

Read the full 219 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE